Reading: Safe and pragmatic use of sodium-glucose co-transporter 2 (SGLT 2) inhibitors: medication co...
Perspective
Safe and pragmatic use of sodium-glucose co-transporter 2 (SGLT 2) inhibitors: medication counseling
Authors:
S. Kalra ,
Bharti Hospital, Karnal, IN
About S.
Department of Endocrinology
A. H. Aamir,
Post Graduate Medical Institute, Hayatabad Medical Complex, Peshawar, PK
About A. H.
Department of Endocrinology & Metabolic diseases
M. F. Amin,
BIRDEM, Dhaka, Bangladesh, BD
About M. F.
Department of Endocrinology
S. Bajaj,
MLN Medical College, Allahabad, IN
About S.
Department of Medicine
U. Bulugahapitiya,
Colombo South Teaching Hospital, Colombo, LK
About U.
Department of Endocrinology
A. K. Das,
Pondicherry Institute of Medical Sciences, Puducherry, IN
About A. K.
Department of Medicine
S. Ghosh,
IGPGMR, Kolkata, IN
About S.
Department of Endocrinology
S. Gunatilake,
Colombo South Teaching Hospital, Colombo, LK
About S.
Department of Endocrinology
S. A. Mahar,
National Institute of Cardiovascular Diseases, Karachi, PK
About S. A.
Department of Medicine
N. Qureshi,
Asgar Ali Hospital, Dhaka, BD
About N.
Department of Endocrinology & Diabetes
S. A. Raza,
Shaukat Khanum Cancer Hospital and Research Centre, Lahore, PK
About S. A.
Department of Medicine
D. Shrestha,
Norvic Hospital, Kathmandu, NP
About D.
Department of Endocrinology
N. Somasundaram,
National Hospital of Sri Lanka, LK
About N.
Department of Endocrinology
M. Sumanatilleke,
Teaching Hospital Karapitiya, Galle, LK
About M.
Department of Endocrinology
A. Wijesinghe
National Hospital of Sri Lanka, LK
About A.
Department of Endocrinology
Abstract
No abstract available
How to Cite:
Kalra, S. et al. , (2016). Safe and pragmatic use of sodium-glucose co-transporter 2 (SGLT 2) inhibitors: medication counseling . Sri Lanka Journal of Diabetes Endocrinology and Metabolism . 6 ( 2 ) , pp . 55–57 . DOI: http://doi.org/10.4038/sjdem.v6i2.7316
Published on 29 Aug 2016.
Peer Reviewed
Downloads
Kalra, S. et al. , (2016). Safe and pragmatic use of sodium-glucose co-transporter 2 (SGLT 2) inhibitors: medication counseling . Sri Lanka Journal of Diabetes Endocrinology and Metabolism . 6 ( 2 ) , pp . 55–57 . DOI: http://doi.org/10.4038/sjdem.v6i2.7316
Kalra S, Aamir AH, Amin MF, Bajaj S, Bulugahapitiya U, Das AK, et al. . Safe and pragmatic use of sodium-glucose co-transporter 2 (SGLT 2) inhibitors: medication counseling . Sri Lanka Journal of Diabetes Endocrinology and Metabolism . 2016; 6 ( 2 ) :55–7 . DOI: http://doi.org/10.4038/sjdem.v6i2.7316
Kalra, S., Aamir, A. H., Amin, M. F., Bajaj, S., Bulugahapitiya, U., Das, A. K., … Wijesinghe, A. (2016). Safe and pragmatic use of sodium-glucose co-transporter 2 (SGLT 2) inhibitors: medication counseling . Sri Lanka Journal of Diabetes Endocrinology and Metabolism , 6 ( 2 ) , 55–57 . DOI: http://doi.org/10.4038/sjdem.v6i2.7316
Kalra, S., A. H. Aamir, M. F. Amin, S. Bajaj, U. Bulugahapitiya, A. K. Das, S. Ghosh, S. Gunatilake, S. A. Mahar, N. Qureshi, S. A. Raza, D. Shrestha, N. Somasundaram, M. Sumanatilleke, and A. Wijesinghe. 2016. Safe and pragmatic use of sodium-glucose co-transporter 2 (SGLT 2) inhibitors: medication counseling 6 , no. 2 : 55–57 . DOI: http://doi.org/10.4038/sjdem.v6i2.7316
